I got a note from one of my NIH doctors yesterday which read, in part:
We have very exciting news to share: we were successfully able to screen your TIL fragments for reactivity against your tumor mutations and found clear “stand outs” which have a high level of reactivity against a subset of the mutations which we are selecting to expand to large numbers for your treatment. We are working now with the cell production facility to get you scheduled for the actual treatment phase ASAP. Your treatment is a priority and I hope we can have a finalized schedule in the very near future.
This is good news, and significant progress. Last year’s crowd-funded Whole Genome Sequencing gave them an effective tool for filtering the TIL cells harvested from my non-therapeutically resected lung tumors. This will improve the odds of success in my forthcoming immunotherapy process.
All we need now is that schedule…